<DOC>
	<DOC>NCT00552292</DOC>
	<brief_summary>The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guidelines for its management.</brief_summary>
	<brief_title>Complications in Hypertension and Obesity</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>Age older 18 years Signed informed consent Blood pressure more than 130 and/or 85 mm Hg Waist circumference more than 80 sm in females and 94 in males and/or BMI more than 25 kg/m2 Dyslipidemia (elevated TG and/or decreased level of HDLP or therapy for high triglyceride level) Fasting glucose more than 5,6 mmol/l Associated clinical conditions (stroke, TIA, MI, heart failure, renal disease, diabetes mellitus) Severe concomitant diseases affecting outcome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>metabolic syndrome</keyword>
	<keyword>hypertension</keyword>
	<keyword>obesity</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>hyperglycemia</keyword>
	<keyword>cardiovascular complications</keyword>
</DOC>